HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE

EarningsPositive

AI Analysis

Summary

Halozyme reported record Q2 2026 revenue of $481 million, beating estimates with 48% YOY growth, and raised full-year 2026 financial guidance citing strong royalty revenue growth of 50% YOY.

Financial Highlights

Revenue

$481 million Q2 2026; guidance $1.835-$1.910 billion full year 2026

Guidance

Total Revenue $1.835-$1.910 billion (31%-37% YOY growth); Royalty Revenue $1.220-$1.245 billion (41%-43% YOY growth)

Importance:6/10

Sentiment:

0.85

earningsrevenue_growthguidance_raiseroyalty_revenue

Related Companies

$HALO

Read the original article

Published by PR Newswire Biotech on August 6, 2026 8:01 PM

Read Original